Yale Researchers Take Stem Cells One Step Closer to Replacing Parathyroid Gland Function
Yale investigators have developed a multistep process that models the biological instructions to create parathyroid gland cells from pluripotent stem cells, a significant milestone along the path toward helping people who lack the hormones released by parathyroid glands.
Is Prevention the Future of SGLT2s? Inzucchi Offers Data That Suggest "Yes"
Groundbreaking trials with SGLT2 inhibitors show patients who did not have type 2 diabetes (T2D) when they started the DAPA-HF trial were 32% less likely to develop the disease if they took dapagliflozin (Farxiga) instead of placebo.Source: AJMC
A COVID-19 Update for our Patients and Families
Smilow Cancer Hospital and our Smilow Cancer Hospital Care Centers are closely monitoring the spread of COVID-19 (Coronavirus) and are taking extra precautions to protect our patients and their families. Patients with cancer often have a weakened immune system, or are immunosuppressed, and are at an increased risk of infection, the flu, and other viruses.
Information for our Patients about COVID–19 from Smilow Cancer Hospital
Smilow Cancer Hospital is closely monitoring the spread of novel coronavirus (COVID-19) and is taking extra precautions to protect our patients and their families. Patients with cancer often have a weakened immune system, or are immunosuppressed, and are at an increased risk of infection, the flu, and other viruses.
A Dream of Sustainable Surgery in Uganda
Yale Medicine pediatric surgeon Doruk Ozgediz, MD, and endocrine surgeon Tobias Carling, MD, PhD participate in medical mission work in Uganda. Although many doctors go on medical missions to provide care for people who wouldn’t be treated otherwise, these surgeons envisioned Uganda as a place that, with some help, could provide its own sustainable surgical care.Source: Yale Medicine
TSH Levels Linked to Papillary Thyroid Cancer, With Sex Differences
Thyroid-stimulating hormone (TSH) levels show a significant association with the risk of papillary thyroid cancer (PTC) that appears gender-based, with lower-than-normal serum TSH levels years before a cancer diagnosis linked to an increased risk of PTC in women, while in contrast a higher-than-normal prediagnostic level is linked to a greater risk in men. Furthermore, increased TSH levels falling even within the normal TSH range show a trend of being associated with a decreased risk of PTC in both genders. "The findings by gender are novel," first author Yawei Zhang, MD, PhD, of the Yale School of Public Health and the Yale Cancer Center, in New Haven, Connecticut, told Medscape Medical News.Source: Medscape
Patricia Peter Named Instructor in Internal Medicine/Endocrinology
Please join us in celebrating Dr. Patricia Peter’s transition from Fellow to Instructor in Internal Medicine (Endocrinology). Since July, Dr. Peter has been seeing patients in the Smilow Endocrine Neoplasia Clinic, the Yale Diabetes Center, and the Yale Health Plan.
New thyroid surgical technique a ‘game-changer,’ Yale-New Haven doctor says
A “game-changer” of a surgical technique allows doctors to operate on the thyroid without leaving a visible scar, according to Dr. Robert Udelsman of Yale-New Haven Hospital, who learned the surgery in Thailand.Source: New Haven Register